Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.22.2.2
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 1,837,810 2,727,695
Value 2,593,297 3,483,182
Common Stock    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 1,837,810 2,727,695
Value $ 2,593,297 $ 3,483,182